EcoR1 Capital as of June 30, 2020
Portfolio Holdings for EcoR1 Capital
EcoR1 Capital holds 48 positions in its portfolio as reported in the June 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Xencor (XNCR) | 10.9 | $147M | 4.5M | 32.39 | |
| Prothena Corp SHS (PRTA) | 7.3 | $99M | 9.4M | 10.46 | |
| Oric Pharmaceuticals (ORIC) | 6.6 | $89M | 2.6M | 33.73 | |
| Morphic Hldg (MORF) | 5.7 | $77M | 2.8M | 27.05 | |
| Kura Oncology (KURA) | 5.5 | $75M | 4.6M | 16.30 | |
| Assembly Biosciences | 5.4 | $74M | 3.2M | 23.32 | |
| Dicerna Pharmaceuticals | 5.1 | $69M | 2.7M | 25.40 | |
| Anaptysbio Inc Common (ANAB) | 5.1 | $69M | 3.1M | 22.34 | |
| Avidity Biosciences Ord (RNA) | 4.4 | $60M | 2.1M | 28.26 | |
| Neoleukin Therapeutics | 4.3 | $59M | 3.5M | 16.60 | |
| Arcus Biosciences Incorporated (RCUS) | 3.3 | $45M | 1.8M | 24.74 | |
| Akouos | 3.3 | $45M | 2.0M | 22.50 | |
| Geron Corporation (GERN) | 3.1 | $42M | 19M | 2.18 | |
| Mirati Therapeutics | 3.0 | $41M | 358k | 114.17 | |
| Ultragenyx Pharmaceutical (RARE) | 3.0 | $41M | 519k | 78.22 | |
| Constellation Pharmceticls I Call Option | 2.7 | $37M | 1.2M | 30.05 | |
| Surface Oncology | 2.4 | $33M | 5.0M | 6.56 | |
| Atreca Cl A Com (BCEL) | 2.3 | $32M | 1.5M | 21.28 | |
| Applied Molecular Trans | 2.1 | $29M | 1.2M | 25.14 | |
| Fate Therapeutics (FATE) | 1.6 | $21M | 620k | 34.31 | |
| Denali Therapeutics (DNLI) | 1.3 | $18M | 734k | 24.18 | |
| Bristol-myers Squibb Right 99/99/9999 | 1.3 | $17M | 4.7M | 3.58 | |
| Cyclerion Therapeutics | 1.2 | $16M | 2.7M | 5.91 | |
| Fulcrum Therapeutics (FULC) | 1.2 | $16M | 882k | 18.29 | |
| Crinetics Pharmaceuticals In (CRNX) | 1.1 | $15M | 860k | 17.52 | |
| Sutro Biopharma (STRO) | 1.0 | $14M | 1.8M | 7.76 | |
| Relmada Therapeutics (RLMD) | 0.7 | $9.0M | 200k | 44.75 | |
| Keros Therapeutics (KROS) | 0.6 | $8.3M | 220k | 37.51 | |
| Glycomimetics (GLYC) | 0.5 | $7.1M | 1.9M | 3.76 | |
| ACADIA Pharmaceuticals (ACAD) | 0.5 | $6.6M | 135k | 48.47 | |
| Evelo Biosciences | 0.5 | $6.1M | 1.3M | 4.90 | |
| Prevail Therapeutics Ord | 0.4 | $5.5M | 367k | 14.90 | |
| Ironwood Pharmaceuticals Com Cl A Call Option (IRWD) | 0.4 | $5.2M | 500k | 10.32 | |
| Exicure | 0.3 | $4.1M | 1.7M | 2.44 | |
| Savara (SVRA) | 0.3 | $3.6M | 1.4M | 2.49 | |
| Magenta Therapeutics | 0.2 | $3.4M | 450k | 7.51 | |
| Lifesci Acquisition Corp Unit 03/31/2025 | 0.2 | $3.3M | 300k | 11.00 | |
| Aclaris Therapeutics (ACRS) | 0.2 | $2.5M | 1.5M | 1.62 | |
| Royalty Pharma Shs Cl A (RPRX) | 0.2 | $2.4M | 50k | 48.56 | |
| Five Prime Therapeutics | 0.2 | $2.3M | 380k | 6.10 | |
| Corvus Pharmaceuticals (CRVS) | 0.1 | $2.0M | 738k | 2.72 | |
| Repare Therapeutics Ord (RPTX) | 0.1 | $1.6M | 50k | 31.02 | |
| Intercept Pharmaceuticals In Call Option | 0.1 | $1.2M | 25k | 47.91 | |
| Meiragtx Holdings (MGTX) | 0.1 | $1.2M | 95k | 12.52 | |
| Xoma Corp Del Com New (XOMA) | 0.1 | $1.0M | 51k | 19.76 | |
| Kaleido Biosciences Ord (KLDO) | 0.0 | $233k | 31k | 7.43 | |
| Equillium (EQ) | 0.0 | $174k | 59k | 2.95 | |
| Pliant Therapeutics (PLRX) | 0.0 | $42k | 1.3k | 32.31 |
